BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33865224)

  • 21. Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning.
    Lai Y; Lin P; Lin F; Chen M; Lin C; Lin X; Wu L; Zheng M; Chen J
    Front Immunol; 2022; 13():1046410. PubMed ID: 36569892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
    Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood-brain barrier and Alzheimer's disease].
    Kuwahara H; Nishida Y; Yokota T
    Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
    Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease: Innate immunity gone awry?
    VanItallie TB
    Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats.
    Zhao HF; Li N; Wang Q; Cheng XJ; Li XM; Liu TT
    Neuroscience; 2015 Dec; 310():641-9. PubMed ID: 26454022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling in Alzheimer's disease brain microvessels.
    Wang S; Qaisar U; Yin X; Grammas P
    J Alzheimers Dis; 2012; 31(1):193-205. PubMed ID: 22531426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.
    Batarseh YS; Bharate SS; Kumar V; Kumar A; Vishwakarma RA; Bharate SB; Kaddoumi A
    ACS Chem Neurosci; 2017 Aug; 8(8):1756-1766. PubMed ID: 28471166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.
    Kant S; Stopa EG; Johanson CE; Baird A; Silverberg GD
    Fluids Barriers CNS; 2018 Dec; 15(1):34. PubMed ID: 30541599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.
    Goldwaser EL; Acharya NK; Sarkar A; Godsey G; Nagele RG
    J Alzheimers Dis; 2016 Sep; 54(2):445-56. PubMed ID: 27497477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
    Chai AB; Leung GKF; Callaghan R; Gelissen IC
    FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
    J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
    Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
    Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The blood brain barrier in Alzheimer's disease.
    Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
    Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: A matter of blood-brain barrier dysfunction?
    Montagne A; Zhao Z; Zlokovic BV
    J Exp Med; 2017 Nov; 214(11):3151-3169. PubMed ID: 29061693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential roles of brain barrier dysfunctions in the early stage of Alzheimer's disease.
    Jian WX; Zhang Z; Chu SF; Peng Y; Chen NH
    Brain Res Bull; 2018 Sep; 142():360-367. PubMed ID: 30153473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk between peripheral immunity and central nervous system in Alzheimer's disease.
    Yang H; Qin Q; Wang M; Yin Y; Li R; Tang Y
    Cell Immunol; 2023; 391-392():104743. PubMed ID: 37451918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.